Redmile Group’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
Redmile Group's OBX Position: Q3 2026 in Review
Redmile Group opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 833,157 shares worth $11.4M. The stake represents 0.84% of the portfolio and ranks #23 among its holdings.
60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- Redmile Group held 833,157 shares of Obsidian Therapeutics worth $11.4M as of Q3 2026.
- Obsidian Therapeutics was a new Redmile Group position in Q3 2026.
- Obsidian Therapeutics made up 0.84% of Redmile Group's portfolio in Q3 2026, its #23 holding.
- 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on Redmile Group's 13F filing for Q3 2026, filed 16 Nov 2026.